Adagio Medical Holdings (ADGM) Depreciation & Amortization (CF) (2023 - 2026)

Adagio Medical Holdings has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $210000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 22.51% year-over-year to $210000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 27.02% YoY) and the FY2025 annual result came in at $970000.0, up 31.08% from the prior year.
• Depreciation & Amortization (CF) slipped to $210000.0 in Q1 2026 per ADGM's latest filing, from $237000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $500000.0 in Q3 2025 and troughed at $100000.0 in Q3 2023.
• A 4-year average of $261300.0 and a median of $254000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) soared 216.0% in 2024, then plunged 36.71% in 2025.
• Over 4 years, Depreciation & Amortization (CF) stood at $133000.0 in 2023, then surged by 137.59% to $316000.0 in 2024, then retreated by 25.0% to $237000.0 in 2025, then slipped by 11.39% to $210000.0 in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $210000.0, $237000.0, and $500000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.